Tridem Bioscience is a privately held biotech company based in Vienna, Austria.
We are focusing on the discovery and development of innovative active immunotherapies based on our proprietary WISIT (WIn the Skin Immune system Trick) technology.
We aim to realize this novel vaccine concept using Parkinson’s disease (PD) as our first indication. PD is the major representative of synucleopathies, a group of neurodegenerative diseases with high-unmet medical need.